A carregar...
Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma
A 20-year-old woman was diagnosed with stage 4 lung adenocarcinoma with an epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation. Although the patient underwent chemotherapy, her lesions progressed. Liquid biopsy for EGFR T790M mutation showed negative results. After administering...
Na minha lista:
| Publicado no: | EXCLI J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Leibniz Research Centre for Working Environment and Human Factors
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806250/ https://ncbi.nlm.nih.gov/pubmed/31645848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1786 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|